Valuation Scienture Holdings, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-15 EDT			5-day change	1st Jan Change
3.380 ^USD	+0.90%		-18.16%	-73.49%

08-13	Scienture Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-12	Scienture Holdings Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy Nasal Spray 10 Mg	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	52.94	20.72	5.503	-	-
Change	-	-60.86%	-73.45%	-	-
Enterprise Value (EV)	52.94	20.72	5.503	5.503	5.503
Change	-	-60.86%	-73.45%	0%	0%
P/E	2.25x	-0.19x	-0.58x	-	0.61x
PBR	-	-	-	-	-
PEG	-	0x	0x	-	-
Capitalization / Revenue	-	48x	1.15x	0.32x	0.14x
EV / Revenue	-	0x	1.15x	0.32x	0.14x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-0x	-0.57x	12.4x	0.38x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	67.25	-67.5	-5.75	-	5.5
Distribution rate	-	-	-	-	-
Net sales ¹	-	0.4316	4.789	17.22	37.98
EBITDA	-	-	-	-	-
EBIT ¹	-	-42.59	-9.606	0.445	14.39
Net income ¹	9.066	-41.51	-9.622	0.135	11.26
Net Debt	-	-	-	-	-
Reference price ²	151.250	12.750	3.350	3.350	3.350
Nbr of stocks (in thousands)	350	1,625	1,643	-	-
Announcement Date	3/26/25	3/30/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCIENTURE HOLDINGS, INC.	-0.58x	-	-	-	5.5M
ELI LILLY AND COMPANY	34.58x	12.46x	26.12x	0.57%	1,077B
JOHNSON & JOHNSON	37.53x	6.26x	17.55x	2.1%	612B
ABBVIE INC.	36.12x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	113.84x	6x	25.7x	2.32%	364B
ROCHE HOLDING AG	20.01x	4.88x	12.13x	2.7%	353B
NOVARTIS AG	20.46x	5.37x	13.21x	2.96%	278B
ASTRAZENECA PLC	21.15x	4.27x	12.26x	2.07%	251B
AMGEN INC.	27.06x	6.97x	12.48x	2.37%	230B
GILEAD SCIENCES, INC.	-44.86x	6.85x	26.64x	2.14%	190B
Average	26.53x	6.82x	18.14x	2.19%	385.65B
Weighted average by Cap.	35.12x	7.99x	19.65x	1.87%